Camp4 Therapeutics Corp (NASDAQ:CAMP)
Camp4 Therapeutics Corp has a live Insider Score.
Scored on 5 qualifying trades from 4 insiders in the last 90 days.
Loses money on what it sells.
- Revenue
- $4.2M
- Net income
- -$107.2M
- Net margin
- -2543.7%
Not enough balance-sheet detail to judge the debt load.
- Total debt
- $2.4M
- Cash
- $87.1M
Comfortably covers what is due within a year.
- Current assets
- $90.0M
- Current liabilities
- $19.1M
- Current ratio
- 4.70
Consumes cash and must keep raising it.
- Operating cash flow
- -$28.6M
- Free cash flow
- -$28.7M
- FCF margin
- -681.2%
Heavy dilution — shareholders are paying for the business.
- Shares outstanding
- 57.9M
- Share growth (1y)
- 187.4%
- Cash runway
- 37 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
CAMP Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 1.78 M | 1.29 M | 348.00 K | 795.00 K | 1.50 M | 858.00 K |
| Revenue Growth (YoY) | 18.84 % | 50.82 % | -46.63 % | — | — | — |
| Cost of Revenue | 0.00 | 520.00 K | 0.00 | 416.00 K | 0.00 | 0.00 |
| Gross Profit | 1.78 M | 774.00 K | 348.00 K | 379.00 K | 1.50 M | 858.00 K |
| SG&A Expense | 4.34 M | 4.21 M | 4.77 M | 4.60 M | 4.18 M | 3.81 M |
| R&D Expense | 10.82 M | 9.64 M | 8.36 M | 9.36 M | 10.34 M | 10.15 M |
| Operating Expenses | 15.16 M | 13.85 M | 13.12 M | 13.54 M | 14.53 M | 13.96 M |
| Operating Income | -13.38 M | -13.07 M | -12.78 M | -13.16 M | -13.03 M | -13.10 M |
| Pretax Income | -33.53 M | -18.33 M | -40.28 M | -15.10 M | -12.59 M | -12.43 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -33.53 M | -18.33 M | -40.28 M | -15.10 M | -12.59 M | -12.43 M |
| EPS (Basic) | -0.58 | -0.32 | -0.78 | -0.55 | -0.62 | -0.64 |
| EPS (Diluted) | -0.58 | -0.32 | -0.78 | -0.55 | -0.62 | -0.64 |
| Shares Outstanding | 57.93 M | 57.92 M | 51.90 M | 20.16 M | 20.16 M | 19.51 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.